Alebund Pharmaceuticals Announces 2026 Interim Results
- Written by PR Newswire
SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period"). During the Reporting Period and up to the date...
Read more: Alebund Pharmaceuticals Announces 2026 Interim Results














